LogicBio Therapeutics, Inc. (LOGC) financial statements (2020 and earlier)

Company profile

Business Address 99 ERIE STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5181
Cash and cash equivalents3381
Short-term investments18 
Restricted cash and investments0 
Other undisclosed current assets21
Total current assets:5382
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment21
Restricted cash and investments10
Total noncurrent assets:31
TOTAL ASSETS:5683
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities43
Accounts payable11
Accrued liabilities32
Total current liabilities:43
Noncurrent Liabilities
Long-term debt and lease obligation10 
Long-term debt, excluding current maturities10 
Total noncurrent liabilities:10 
Total liabilities:133
Stockholders' equity
Stockholders' equity attributable to parent4280
Common stock00
Additional paid in capital110107
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(67)(27)
Total stockholders' equity:4280
TOTAL LIABILITIES AND EQUITY:5683

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Operating expenses(41)(18)
Operating loss:(41)(18)
Nonoperating income10
Other nonoperating expense(0)(0)
Interest and debt expense(1) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes1(0)
Loss from continuing operations before equity method investments, income taxes:(40)(18)
Other undisclosed income from continuing operations before income taxes 0
Loss from continuing operations before income taxes:(40)(18)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(40)(18)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(40)(18)
Comprehensive loss:(40)(18)
Other undisclosed comprehensive income, net of tax, attributable to parent00
Comprehensive loss, net of tax, attributable to parent:(40)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: